Stericycle, Inc. Reports Results for the Second Quarter and Year to Date 2016

Go back to Stericycle, Inc. Reports Results for the Second Quarter and Year to Date 2016

Imperial Capital Downgrades Stericycle (SRCL) to Underperform

July 29, 2016 10:26 AM EDT

Imperial Capital downgraded Stericycle (NASDAQ: SRCL) from In-Line to Underperform with a price target of $93.50 (from $100.00).

Analyst Scott Levine commented, "We are lowering our rating on SRCL shares to Underperform from In-Line, and are lowering our one-year price target to $93.50 from $100. Our... More

Stericycle (SRCL) Reports In-Line Q2 EPS, Revenue Light

July 28, 2016 4:18 PM EDT

Stericycle (NASDAQ: SRCL) reported Q2 EPS of $1.18, in-line with the analyst estimate of $1.18. Revenue for the quarter came in at $891.6 million versus the consensus estimate of $912.79 million.

For earnings history and earnings-related data on Stericycle (SRCL) click here.

... More